证券代码：600328 证券简称：中盐化工 公告编号：（临）2025-058 中盐内蒙古化工股份有限公司 关于参股公司中盐(内蒙古)碱业有限公司 签署采矿权出让合同的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、中盐碱业竞得天然碱采矿权基本情况 2025 年 6 月 16 日，中盐碱业参与内蒙古自治区通辽市奈曼旗大沁他拉 地区天然碱采矿权（以下简称"天然碱采矿权"）竞拍，2025 年 6 月 17 日， 收到通辽市自然资源局《成交确认书》；2025 年 7 月 9 日，通过公示期公 示后，中盐碱业和内蒙古自治区通辽市自然资源局签署《采矿权出让合同》， 中盐碱业以 68.0866 亿元取得天然碱采矿权。中盐碱业将按照《财政部自 然资源部税务总局关于印发〈矿业权出让收益征收〉的通知》和内蒙古自 治区相关规定在收到缴款通知书之日起 30 日内缴纳出让成交价 68.0866 亿 元。 二、《采矿权出让合同》主要条款 甲方 （出让人）：通辽市自然资源局 乙方 （受让人）：中盐(内蒙古)碱业有限公司 重要内容提示： ●签 ...

Core Viewpoint - Zhongyan Chemical (600328) announced that its associate company, Zhongyan Bicarbonate Co., Ltd., signed a mining rights transfer contract with the Tongliao Natural Resources Bureau to acquire the natural soda mining rights in the Nai Manqi Da Qin Ta La area for 6.809 billion yuan [1] Group 1 - The mining rights cover an area of 28.85 square kilometers and the extraction method will be underground [1] - The contract has an initial registration period of 30 years [1] - Zhongyan Bicarbonate is required to pay the transaction price within 30 days of receiving the payment notice and will pay an annual transfer income of 2.9% of sales revenue [1] Group 2 - Zhongyan Chemical's major asset restructuring is progressing as planned [1]

股票代码：600328 中盐内蒙古化工股份有限公司 2025 年第四次临时股东会资料 中盐内蒙古化工股份有限公司 一、会议召开的日期、时间： （一）现场会议召开时间为：2025 年 7 月 15 日上午 9:30 时； （二）网络投票时间为：通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00； 通过互联网投票平台的投票时间为股东会召开当日的 9:15-15:00。 二、会议的表决方式：本次会议采取现场投票与网络投票相结合 的方式，公司将使用上海证券交易所交易系统向全体股东提供网络形 式的投票平台，股东可以在网络投票时间内通过上述系统行使表决权。 但同一股份只能选择一种表决方式。同一股份通过现场、网络或其他 方式重复进行表决的，以第一次投票结果为准。 三、现场会议召开地点：中盐内蒙古化工股份有限公司 1605 会议 室 中盐内蒙古化工股份有限公司 2025 年第四次临时股东会资料 中盐内蒙古化工股份有限公司 四、现场会议议程 （一）主持人宣布会议开始 （二）宣布现场到会股东、股东代表人及代表有表决权的股份数 额。 （三）介绍出席现场 ...

中盐内蒙古化工股份有限公司 2025 年第四次临时股东会资料 中盐内蒙古化工股份有限公司 2025 年第四次临时股东会资料 股票代码：600328 2025 年 7 月 15 日 1 中盐内蒙古化工股份有限公司 2025 年第四次临时股东会资料 中盐内蒙古化工股份有限公司 2025 年第四次临时股东会会议议程 一、会议召开的日期、时间： （一）现场会议召开时间为：2025 年 7 月 15 日上午 9:30 时； （二）网络投票时间为：通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00； 通过互联网投票平台的投票时间为股东会召开当日的 9:15-15:00。 二、会议的表决方式：本次会议采取现场投票与网络投票相结合 的方式，公司将使用上海证券交易所交易系统向全体股东提供网络形 式的投票平台，股东可以在网络投票时间内通过上述系统行使表决权。 但同一股份只能选择一种表决方式。同一股份通过现场、网络或其他 方式重复进行表决的，以第一次投票结果为准。 三、现场会议召开地点：中盐内蒙古化工股份有限公司 1605 会议 室 四、现场会议议程 ...

Group 1 - The A-share market has seen an acceleration in the disclosure of semi-annual performance forecasts, with 54 companies announcing their forecasts as of July 6, 2025, indicating a slight increase of 11 companies, 3 companies turning losses into profits, 4 companies maintaining profits, and 21 companies expecting profit growth [1][4] - Companies like Taotao Automotive (301345) have expressed confidence in continued growth for the second half of the year, expecting a net profit of 310 million to 360 million yuan for the first half of 2025, representing a year-on-year increase of 70.34% to 97.81% [2][4] - Jingbeifang (002987) experienced significant stock price fluctuations after intensive institutional research, with a cumulative price deviation exceeding 20% over three consecutive trading days [2][4] Group 2 - Chipong Micro (芯朋微) expects a revenue of approximately 630 million yuan for the first half of 2025, an increase of about 176 million yuan or 38% year-on-year, with a net profit forecast of around 90 million yuan, reflecting a growth of approximately 104% [4] - Daotong Technology (道通科技) anticipates a net profit of 460 million to 490 million yuan for the first half of 2025, representing a year-on-year growth of 19% to 26.76% [4] - Changchuan Technology (长川科技) projects a net profit of 360 million to 420 million yuan for the first half of 2025, indicating a year-on-year increase of 67.54% to 95.46% due to rapid growth in the integrated circuit industry and strong customer demand [5]

Group 1 - The company has successfully acquired exploration rights for the natural soda ash mine in Jilantai Town, Alxa Left Banner, Inner Mongolia, through a public auction for RMB 929,000 [1] - The geological analysis indicates the potential presence of soluble inorganic salt natural soda ash in the exploration area, which is located in a geologically favorable position with significant sediment thickness and stable deposition conditions [1] - The exploration area is situated in the Jilantai depression, which has a complete development of Triassic strata and extensive Upper Cretaceous strata, suggesting favorable conditions for the formation of natural soda ash deposits [1] Group 2 - The company will conduct further exploration to assess the viability of transitioning from exploration to extraction based on the findings [2] - The company emphasizes the importance of ongoing monitoring of the exploration progress and will fulfill its information disclosure obligations to investors [2]

Group 1: Company Announcements - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and international brand image [1] - Saisir reported June sales of 46,086 new energy vehicles, a year-on-year increase of 4.44%, with a total of 172,100 units sold in the first half of the year, down 14.35% year-on-year [1] - Hangzhou High-tech announced a change in controlling shareholder to Jirong Weiye, with stock resuming trading on July 2, 2025 [1] Group 2: Financial Performance - Guomai Technology expects a net profit of 125 million to 156 million yuan for the first half of 2025, a year-on-year increase of 60.52% to 100.33% [2] - Kid King anticipates a net profit of 120 million to 160 million yuan for the first half of 2025, representing a year-on-year growth of 50% to 100% [2] - Mould Technology received a project from a well-known North American electric vehicle company, with expected total sales of 1.236 billion yuan over five years [3] Group 3: Regulatory and Compliance - *ST Yuancheng is under investigation by the China Securities Regulatory Commission for suspected false disclosures in financial reports [4] - The company received a notice of investigation on July 1, 2025, which may lead to significant penalties and potential delisting [4] Group 4: Market Activity - Changcheng Military Industry's stock has experienced significant volatility, with a cumulative price deviation exceeding 20% over three trading days, indicating potential irrational speculation [5] - Anglikang has only one innovative drug project, ALK-N001, currently in Phase I clinical trials, highlighting the long and uncertain nature of drug development [6] Group 5: Sales and Contracts - Beiqi Blue Valley's subsidiary reported a 139.73% year-on-year increase in sales for the first half of the year [7] - Dong'an Power's engine sales in June increased by 82.79% year-on-year [7] - Pudong Construction's subsidiary won multiple major projects with a total bid amount of 1.964 billion yuan [7]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

证券代码：600328 证券简称：中盐化工 公告编号：2025-055 中盐内蒙古化工股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/12/7 | | --- | --- | | 回购方案实施期限 | 用于员工持股计划或股权激励用途的， 待股东大 | | | 会审议通过后 12 个月 ；用于维护公司价值及股 | | | 东权益用途的，待股东大会审议通过后 个月。 3 | | 预计回购金额 | 5,000万元~10,000万元 | | 回购用途 | □减少注册资本 | | | √用于员工持股计划或股权激励 | | | □用于转换公司可转债 | | | √为维护公司价值及股东权益 | | 累计已回购股数 | 903.657万股 | | 累计已回购股数占总股本比例 | 0.616% | | 累计已回购金额 | 6,704.11万元 | | 实际回购价格区间 | 6.71元/股~7.98元/股 | 本次回购符合相关法律法规和公司回购股份方案的要求。 关于以集中竞价交易 ...

1.勘查项目名称：内蒙古自治区阿拉善左旗吉兰泰镇天然碱矿普查探矿 权 证券代码：600328 证券简称：中盐化工 公告编号：（临）2025-056 中盐内蒙古化工股份有限公司 关于竞拍获得探矿权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、取得探矿权的基本情况 2025 年 5 月 15 日，内蒙古自治区自然资源网上交易系统公开挂牌出让 内蒙古自治区阿拉善左旗吉兰泰镇天然碱矿普查探矿权（以下简称"吉兰 泰天然碱探矿权"）。该勘查区块从地质构造特征和沉积学等方面分析， 存在可溶性无机盐天然碱的可能，为此在吉兰泰区域进行风险勘探，以期 发现可溶性天然碱矿藏。区块所处的吉兰泰凹陷位于河套盆地临河坳陷南 部，三叠系地层发育齐全，厚度巨大；白垩系上部地层在该区域广覆式发 育；勘查规划区块所处构造位置位于吉兰泰凹陷相对较低位置（海拔相对 低位置），沉积厚度大，地层层序全，沉积稳定，对地层判断和无机盐储 存在条件有利。根据相关地质资料分析，吉兰泰凹陷白垩系地层中含有大 量碳酸盐岩，与同一地质年代形成的天然碱矿具有相类似的 ...